Dr. Suman Karanth

• Dr Suman is the principal investigator for the trial of Lomustine - Temazolamide combination along with radiation as an adjuvant treatment of newly diagnosed Glioblastomas; A prospective open-label , phase 2 feasibility study.

• Member, American Society of Clinical Oncology [ASCO]

• Member of European Society of Medical Oncology [ESMO]

• Dendritic cell therapy administration & Immunotherapy

• Solid malignancy management  - areas of Interest being Neuro- oncology and GI oncology

• 1st place in Oncology quiz held at 9th conference of SAARC Federation of Oncology 2014

• Held the post of “Quality Champion” in the Department of Medical Oncology; Medanta – The Medicity; Gurgaon [2017-2019]

• Best Paper Presentation Award For Paper Titled “Metabolic Syndrome”: Incidence In Patients With Acute Coronary Syndrome At 14th National Conference Of Hypertension Society Of India

• Best Paper Presentation Award For Paper Titled “Total Lymphocyte Count (TLC ) As A Surrogate Marker For Absolute Cd4+ Count In Hiv – Infected Persons” At Silver Kapicon 2007

• Over 25 publications in International and Indian journals